Label reading

Catuaba: Three Plants, One Name

“Catuaba” is not one plant. It is a Brazilian folk name applied, by the researchers’ own published admission, to at least three botanically unrelated species, and a peer-reviewed chemistry paper has tested commercial catuaba products and found the identity question is not settled by the label alone. VigorHorse’s own panel just says “Catuaba Extract,” third of nine names, with no species given.

By VigorHorse Team · Last updated September 25, 2026 · 10 min read · Label reading

Three plants, one commercial name

Most ingredients on a supplement label map to one Latin binomial. Catuaba does not. It is a common name used across Brazilian folk medicine for a bark sold as an aphrodisiac and general tonic, and the plant behind that name has never been standardized in trade the way, say, ashwagandha or maca has.

The clearest statement of the problem comes from the researchers who study it, not from an outside critic. A 2008 chemistry paper opens its introduction by stating plainly that “the identity of the plant material employed is often uncertain,” that the species recognised by the Brazilian Pharmacopeia is Anemopaegma arvense (family Bignoniaceae), and that “many other plants, regionally known as Catuaba, are commercialised.” That is a peer-reviewed acknowledgment that the name on a bag or a blend line does not reliably specify a species.

Three unrelated or loosely related plants, one shared common name, and a label that (like most in this category) does not print the Latin binomial.

The chemistry paper that tested the problem directly

Daolio and colleagues (2008) set out to classify commercial catuaba samples using proton NMR and HPLC, explicitly because a chemical marker approach was not giving a complete picture of what was actually in the products on shelves. They used a metabolomics approach, applying principal component analysis to the full spectral profile of each sample rather than hunting for one marker compound.

The point of building that method at all is the finding. If commercial catuaba were chemically uniform, nobody would need a multivariate technique to sort samples by profile. The paper exists because the samples were not uniform, and it produced a working method precisely to characterise how they differed.

A separate, more targeted paper by Beltrame and colleagues (2006) developed a validated HPLC method to quantify one specific marker compound, cinchonain Ib, in authentic Trichilia catigua bark and in commercial phytopharmaceuticals sold as catuaba — again, a quality-control method built specifically because verifying what is actually in a catuaba product is not straightforward from the label.

What Trichilia catigua's research actually shows

Of the three plants, Trichilia catigua has the most published pharmacology, all of it preclinical.

Five studies, all preclinical, none measuring libido or sexual behavior. The consistent theme is mood and cognition, run by a single Brazilian research group at the State University of Maringá.

Campos and colleagues is the founding paper of this line of work, and it is explicit about the traditional use it was testing: the introduction to the 2011 follow-up study by the same broader group states that Trichilia catigua preparations “have been popularly used in Brazil as a tonic for the treatment of fatigue, stress, impotence, and deficiency of memory.” The word impotence appears in the ethnopharmacological background of these papers. It does not appear as a tested outcome in any of them. What got tested, every time, was mood (via the forced swim and tail suspension tests, standard rodent screens for antidepressant-like activity) and, in the antifatigue paper, physical endurance.

The other two species, briefly

Anemopaegma arvense, the pharmacopeia's official catuaba, turns up in the botanical and chemical literature (population genetics, chemical profiling) but this page did not find a pharmacology paper testing it against a behavioral or physiological endpoint. That is itself informative: the plant with the official designation is the least studied of the three for actual biological effect.

Valverde and colleagues (2008) tested Anemopaegma mirandum, a third and separate species also sold as catuaba, in human neuroblastoma cells exposed to rotenone, a compound used to model Parkinson's-disease-like cell death. The extract showed a cytoprotective effect, preserving cell viability and mitochondrial structure. This is a genuinely interesting neuroprotection finding, and it belongs to a third plant, tested in a cell line, for a Parkinson's-relevant endpoint that has nothing to do with the vitality claim either.

So across all three plants that share the catuaba name, the pattern repeats: real, specific, peer-reviewed pharmacology exists, and none of it is a human libido or sexual-function study.

What VigorHorse's own label does and does not say

The VigorHorse Supplement Facts panel lists “Catuaba Extract” as the third name in its proprietary blend, printed as-is, with no Latin binomial. That is standard practice across this entire product category and is not a flaw specific to this label; it is worth naming here because it means the identity question this article raises cannot be resolved by looking at the bottle.

Whichever plant was actually used, the labeling rule that governs a proprietary blend still applies: the nine names are printed in descending order of predominance, and catuaba's position, third, places it ahead of six of the other eight names, including the fully broken-out 5 mg caffeine line.

Third of nine names, and what that bounds

The blend totals 82 mg across all nine names, footnoted as roughly equivalent to 567 mg of dry powders. Caffeine, fifth on the list, is the only individually printed figure at 5 mg. Catuaba's own amount is not printed, and being third does not by itself say how far above or below caffeine's 5 mg it sits, only that it outranks the five names below it.

Reading a folk name honestly

1. Treat “catuaba” as a category, not a species, until a label specifies which plant is inside it. Most labels, including this one, do not.
2. The best-studied species, Trichilia catigua, has real preclinical evidence for mood and cognition, from a consistent research group, using standard rodent screening tests.
3. The traditional impotence claim is named in the ethnopharmacological background of these papers and has not been the subject of a controlled test in any of them, in any species.
4. A chemistry paper built specifically to sort commercial catuaba samples is itself evidence that the trade name covers real variation, not a footnote to ignore.
5. Third of nine names is real, bounded information about rank, not a dose, and not a species identification.

None of this means catuaba does not belong on a label like this one. It means the honest description of catuaba is “a folk name covering at least three plants, the best-studied of which has real rodent evidence for mood, not a single verified species with a human libido trial behind it.” That is a longer sentence than most marketing copy allows, which is exactly why it belongs here instead.

References